Research Article
An UPLC-MS/MS Method for Determination of Osimertinib in Rat Plasma: Application to Investigating the Effect of Ginsenoside Rg3 on the Pharmacokinetics of Osimertinib
Table 6
Pharmacokinetic parameters of osimertinib following oral administration (10 mg/kg) to male rats in the presence or absence of Rg3 (5 mg/kg, 7 days, i.g., n = 6 for each).
| ||||||||||||||||||||||||||||||||||||
Values are mean ± SD. |